WeVote
Log In

Bill

Bill

HB 209

Health Care Providers - Assisted Reproductive Treatment - Informed Consent and Fraud

2026 Regular Session Introduced by Nick Allen

Maryland bill requiring healthcare providers to obtain informed consent and establish fraud protections for assisted reproductive treatment procedures.

First Reading Health
0
WeVote Research Nonpartisan
Bill Summary · HB 209

Legislative bill overview

HB 209 establishes informed consent requirements and anti-fraud protections for assisted reproductive treatment (ART) in Maryland. The bill appears designed to ensure patients receive comprehensive information before undergoing ART procedures and to establish accountability mechanisms for healthcare providers offering these services.

Why is this important

Assisted reproductive treatments represent significant financial, emotional, and physical commitments for patients, often involving thousands of dollars and multiple procedures. Clear informed consent and fraud protections help prevent exploitation and ensure patients make decisions based on accurate information about success rates, risks, costs, and alternatives.

Potential points of contention

  • Scope and specificity: The bill's exact requirements for informed consent language and disclosures remain unclear from available information; overly prescriptive requirements could burden providers while minimal requirements may not adequately protect patients
  • Compliance costs: New documentation and disclosure requirements could increase administrative burden and costs for fertility clinics, potentially affecting service accessibility or pricing
  • Definition of fraud: Without clear definitions, disputes may arise over what constitutes fraudulent misrepresentation of success rates, qualifications, or treatment options, creating legal uncertainty

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.